AstraZeneca (AZN) free cash flow

Free cash flow · fiscal 2025
$8.67B

AstraZeneca (AZN) generated free cash flow of $8.67B in fiscal 2025 (the year ended December 31, 2025). That is 19.2% higher than the $7.28B of fiscal 2024. Figures as of 18 Nov 2026, 12:25 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$8.67B
Change on fiscal 2024
+19.2%
Highest on record
$8.67Bfiscal 2025
Lowest on record
$6.57Bfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

AstraZeneca free cash flow, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $8.67B in fiscal 2025 and the lowest $6.57B in fiscal 2023.

History · 4 fiscal years

Free cash flow by fiscal year

AstraZeneca free cash flow, year by year

AstraZeneca (AZN) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$8.67B 19.2% up
2024$7.28B 10.8% up
2023$6.57B 9.3% down
2022$7.24B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of AstraZeneca and comparable companies
CompanyFree cash flowFiscal year
Merck & Co MRK$12.36B2025
UnitedHealth Group UNH$16.08B2025
Novartis NVS$15.24B2025
AstraZeneca AZN$8.67B2025
Thermo Fisher Scientific TMO$6.29B2025
Amgen AMGN$8.10B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AZN

AstraZeneca, figure by figure

AstraZeneca (AZN) overview: price, valuation and scorecardAll health care companies by market value

AstraZeneca free cash flow: questions and answers

What is AstraZeneca's free cash flow?

AstraZeneca (AZN) generated free cash flow of $8.67B in fiscal 2025 (the year ended December 31, 2025). That is 19.2% higher than the $7.28B of fiscal 2024.

What are the highest and lowest free cash flow figures on record for AstraZeneca?

Across the 4 fiscal years on record (2022–2025), the highest was $8.67B in fiscal 2025 and the lowest $6.57B in fiscal 2023.

How is AstraZeneca's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For AstraZeneca it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AstraZeneca (AZN) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/AZN/free-cash-flow

Underlying data: Yahoo Finance.